Ignite Creation Date:
2025-12-24 @ 5:04 PM
Ignite Modification Date:
2026-01-04 @ 3:25 AM
Study NCT ID:
NCT03641950
Status:
COMPLETED
Last Update Posted:
2018-08-22
First Post:
2018-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm.
Sponsor:
Hugel
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2015-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-19
First Submit QC Date:
None
Study First Post Date:
2018-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-20
Last Update Post Date:
2018-08-22
Last Update Post Date Type:
ACTUAL